摘要:
The present invention is related to compounds, their intermediates, processes for their preparation and use, and pharmaceutical compositions comprising the compounds. The novel compounds are useful in therapy, and in particular for the treatment of viral infection, particularly HIV infection.
摘要:
A presente invenção se refere a derivados ftalimídicos de compostos antiinflamatórios não-esteróides e/ou moduladores de TNF-α, bem como a um processo de obtenção de ditos derivados, as composições farmacêuticas contendo tais derivados e seus usos, incluindo o uso no tratamento de doenças inflamatórias, principalmente aquelas relacionadas a processos inflamatórios crônicos como artrite reumatóide e doenças inflamatórias intestinais (por exemplo, doença de Crohn) e utilização de ditas composições como medicamentos antipiréticos, analgésicos e anti-agregantes plaquetários.
摘要:
The present invention relates to phthalimide derivatives of non-steroidal anti-inflammatory compounds and/or TNF-a modulators, to a method for producing these derivatives, to pharmaceutical compositions containing these derivatives, and to uses thereof, including the use for the treatment of inflammatory diseases, in particular those associated with chronic inflammatory conditions, such as rheumatoid arthritis, and inflammatory intestinal diseases (such as Crohn's disease), and to the use of these compositions as antipyretics, analgesics and platelet aggregation inhibitors.
摘要:
The present invention relates to diterpene derivatives prepared from the components which are extracted from Acanthopanax Koreanum and represented by Chemical Formula (1).
摘要:
The invention provides novel compounds of formula (I), wherein: R1 is a radical derived from one of the known ring systems; R2 is a phenyl radical optionally substituted; Xn represents a birradical selected from the group consisting of: -(CH2)1-4-, (C2-C4)-alkenyl, (C2-C4)alkynyl, -S-(CH2)1-3-#, and - (CH2)1-3-O-#; wherein the symbol # indicates the position at which Xn is attached to R1; Yn is a birradical selected from the group consisting of: - (CH2)2-4-, -S-(CH2)1-3#, and -O-(CH2)1-3-#,; wherein the symbol # indicates the position at which Yn is attached to R2; and R3 is a radical selected from the group consisting of: -OR4. The compounds of formula (I) are useful in the treatment of cancer.
摘要:
The present invention relates to salts of Memantine and COX-INHIBITORs, their crystal form, the processes for preparation of the same and their uses as medicaments, more particularly for the treatment of pain.
摘要:
Carboxylic acid derivatives represented by the following general formula (I) and nontoxic salts thereof: (I) wherein R 1 represents COOH, COOR 4 (wherein R 4 represents alkyl, etc.), etc.; A represents alkylene, etc.; R 2 represents alkyl, etc.; m is 0, etc.; B represents a benzene ring, etc.; Q represents an alkylene−Cyc 2 (wherein Cyc 2 represents a heterocycle, etc.), an alkylene−o−benzene ring, etc.; D represents O−alkylene, NHCO−alkylene, etc.; and R 3 represents a benzene ring, a naphthalene ring, etc. Because of binding to PEG2 receptors, in particular, subtype EP3 and/or subtype EP4 and having antagonism, the compounds represented by the general formula (I) are useful in preventing and/or treating diseases such as pain.
摘要翻译:由下列通式(I)表示的羧酸衍生物及其无毒盐:(I)其中R 1表示COOH,COOR 4,其中R 4, / sp>表示烷基等)等; A表示亚烷基等; R 2表示烷基等; m为0等 B代表苯环等; Q表示亚烷基-Si 2(其中Cyc 2表示杂环等),亚烷基-O-苯环等; D表示O-亚烷基,NHCO-亚烷基等; R 3代表苯环,萘环等。由于与PEG2受体特别是亚型EP3和/或亚型EP4的结合并具有拮抗作用,所以由通式( I)可用于预防和/或治疗疼痛等疾病。
摘要:
Provided herein are bicyclic compounds for decreasing the expression of bacterial virulence factors thereby preventing, mitigating, or treating bacterial infection,
摘要:
The invention provides compounds and salts thereof as d herein. The invention also provides pharmaceutical compositions comprising a compound disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection, treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds disclosed herein.